Blood samples were collected while the children were in the hospital, and again at six and 12 months after their injury. They ...
The legendary DJ and artist looks back on the decades it takes to truly build a world — while existing totally in the present ...
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
Final 2025 global cohort onboarding, with applications now open for 2026WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the ...
Long-buried traces of Denisovan DNA have resurfaced in modern human genomes — and they may still be working for us today.
Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...
Scientists discovered that the protein RPA plays a critical and previously unconfirmed role in stimulating telomerase to ...
Cross-species functional genomics identify ribosomal protein genes as key regulators of cardiomyocyte proliferation and heart development, implicating them as candidate modifiers for HLHS and ...
Two mutated alleles of the cystic fibrosis transmembrane conductance regulator (CFTR) gene result in the autosomal recessive ...
New research combines data scrambling with message hiding for stronger security. Data is first converted to RNA code, then encrypted with unpredictable keys & concealed within images. Altering image ...
Dyne Therapeutics, citing trial data, said it will ask the FDA to approve DYNE-251, its therapy for DMD amenable to exon 51 skipping.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback